Provided by Tiger Fintech (Singapore) Pte. Ltd.

IMMUNOTECH-B

4.220
+0.1704.20%
Volume:394.00K
Turnover:1.62M
Market Cap:2.17B
PE:-10.63
High:4.220
Open:4.080
Low:3.970
Close:4.050
Loading ...

HK Movers|Pharma Shares Rallied. CSPC Pharma Up 9%; 3SBio Up 4%; Yihai Up 3%; Genscript Bio And JXR Up 2%.

Tiger Newspress
·
06 Jun

HK Movers|HK Pharma Shares Kept Rally. Zai Lab Up 7%; Hutchmed Up 6%; Immunotech Up 5%

Tiger Newspress
·
05 Jun

HK Movers|Pharma Shares Jumped. Innovent Bio Up 15%; Zai Lab Up 5%; Junshi Bio And CSPC Pharma Up 4%

Tiger Newspress
·
04 Jun

HK Movers|HK's Pharma Shares Jumped. Medlive Up 8%; Sihuan Pharm And Junshi Bio Up 7%; Pharmaron And Fosun Pharma Up 5%

Tiger Newspress
·
03 Jun

Immunotech Biopharm CEO/CTO Resigns

MT Newswires Live
·
02 Jun

Immunotech Biopharm Ltd. Announces Resignation of CEO and CTO, Appoints Acting CEO

Reuters
·
30 May

Immunotech Biopharm - Wang Yu Resigns as CEO and Executive Director

THOMSON REUTERS
·
30 May

Immunotech Biopharm Ltd - Zhang Jian Appointed as Acting CEO

THOMSON REUTERS
·
30 May

Immunotech Biopharm Ltd. Conducted Annual General Meeting

Reuters
·
23 May

HK Movers | HK's Biotech Shares Soar. Asymchem up 15%; Laekna up 13%; Ascletis, CanSinoBIO up 9%

Tiger Newspress
·
21 May

HK Movers | HK's Biotech Shares Soar. Cstone Pharma Soars 20%; RemeGen up 10%; Ascletis up 6%

Tiger Newspress
·
20 May

HK Movers | HK's Biotech Shares Pull Back. Alphamab, Cstone Pharma, Ascletis down about 10%; Immuneonco, Laekna down over 9%

Tiger Newspress
·
12 May

Stock Track | Immunotech Biopharm Plummets 5.39% Despite Narrowed Losses in 2024

Stock Track
·
01 Apr

Stock Track | Immunotech Biopharm Plummets 5.39% Despite Narrowed Losses in 2024

Stock Track
·
01 Apr

Immunotech Biopharm's 2024 Loss Narrows

MT Newswires Live
·
01 Apr

Immunotech Biopharm FY Pretax Profit RMB -186.4 Million

THOMSON REUTERS
·
31 Mar

BRIEF-Immunotech Biopharm Says Conditional New Drug Application Of EAL Accepted By NMPA

Reuters
·
31 Mar

Immunotech Biopharm Ltd (HKG:6978) Top Key Executive Zheng Tan, the company's largest shareholder sees 15%reduction in holdings value

Simply Wall St.
·
06 Mar

Immunotech Biopharm - Center for Drug Evaluation Agreed Group May Submit Application for Conditional Approval for Core Product Candidate, Eal

THOMSON REUTERS
·
28 Feb